Terms: = Kidney tumors AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK
284 results:
1. Development of crizotinib-associated renal cyst in a non-small cell lung cancer patient with alk fusion: a case report and review of the literature.
Zhang P; Xu J; Wu Q; Qian J; Wang S
Diagn Pathol; 2024 Apr; 19(1):58. PubMed ID: 38616252
[TBL] [Abstract] [Full Text] [Related]
2. [A case of crizotinib-associated renal cysts].
Quan LL; Huang P; Liang YC; Chen FW; Liu SB; Xin WW
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):356-359. PubMed ID: 38599812
[TBL] [Abstract] [Full Text] [Related]
3. The New WHO Category of "Molecularly Defined Renal Carcinomas": Clinical and Diagnostic Features and Management Implications.
Kanakaraj J; Chang J; Hampton LJ; Smith SC
Urol Oncol; 2024 Jul; 42(7):211-219. PubMed ID: 38519377
[TBL] [Abstract] [Full Text] [Related]
4. Robot-assisted single-port retroperitoneal partial nephrectomy with a novel purpose-built single-port robotic system with deformable surgical instruments.
Zhang C; Wang Z; Jing T; Wei Y; Guo F; Zhang Z; Xiao C; Wang Y; Xu H; Wu X; Tang S; Yang B; Wang S; Xu B; Zhu Q; Xia D; Wang L
World J Urol; 2024 Mar; 42(1):134. PubMed ID: 38478100
[TBL] [Abstract] [Full Text] [Related]
5. Unlocking Prognostic Genes and Multi-Targeted Therapeutic Bioactives from Herbal Medicines to Combat Cancer-Associated Cachexia: A Transcriptomics and Network Pharmacology Approach.
Muthamil S; Muthuramalingam P; Kim HY; Jang HJ; Lyu JH; Shin UC; Go Y; Park SH; Lee HG; Shin H; Park JH
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203330
[TBL] [Abstract] [Full Text] [Related]
6. Update on Selected High-grade Renal Cell Carcinomas of the kidney: FH-deficient, alk-rearranged, and Medullary Carcinomas.
Chen YB
Adv Anat Pathol; 2024 Mar; 31(2):118-125. PubMed ID: 38145398
[TBL] [Abstract] [Full Text] [Related]
7. alk-rearranged renal cell carcinoma (alk-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey.
Doğan K; Onder E
Pathol Res Pract; 2024 Jan; 253():154951. PubMed ID: 38039739
[TBL] [Abstract] [Full Text] [Related]
8. Genomic alterations and diagnosis of renal cancer.
Zhang X; Bolck HA; Rupp NJ; Moch H
Virchows Arch; 2024 Feb; 484(2):323-337. PubMed ID: 37999735
[TBL] [Abstract] [Full Text] [Related]
9. [Correlation between preoperative platelet parameters and clinicopathological features of differentiated thyroid cancer].
Wang X; Liu W; Zhao M
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Oct; 37(10):796-800. PubMed ID: 37828882
[No Abstract] [Full Text] [Related]
10. Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years.
Fan B; Yokoyama M; Kobayashi M; Nakamura Y; Fujiwara M; Ishikawa Y; Fukuda S; Waseda Y; Tanaka H; Yoshida S; Fujii Y
Int J Urol; 2024 Feb; 31(2):119-124. PubMed ID: 37828800
[TBL] [Abstract] [Full Text] [Related]
11. Causal associations between gut microbiota and urological tumors: a two-sample mendelian randomization study.
Mingdong W; Xiang G; Yongjun Q; Mingshuai W; Hao P
BMC Cancer; 2023 Sep; 23(1):854. PubMed ID: 37697271
[TBL] [Abstract] [Full Text] [Related]
12. Randomized Controlled Feasibility Trial of Robot-assisted Versus Conventional Open Partial Nephrectomy: The ROBOCOP II Study.
Kowalewski KF; Neuberger M; Sidoti Abate MA; Kirchner M; Haney CM; Siegel F; Westhoff N; Michel MS; Honeck P; Nuhn P; Kriegmair MC
Eur Urol Oncol; 2024 Feb; 7(1):91-97. PubMed ID: 37316398
[TBL] [Abstract] [Full Text] [Related]
13. [Analysis of prognosis and related factors in oldest-old patients with left-side or right-side colon cancer after hemicolectomy].
An Q; Shi JX; Cui J; Li ZJ; Ma FH; Xiao G; Jia WW; Tang DN; Zhao G; Wu GJ
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1666-1672. PubMed ID: 37302856
[No Abstract] [Full Text] [Related]
14. Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab.
McManus HD; Zhang D; Schwartz FR; Wu Y; Infield J; Ho E; Armstrong AJ; George DJ; Kruse D; Gupta RT; Harrison MR
Clin Genitourin Cancer; 2023 Dec; 21(6):e429-e437.e2. PubMed ID: 37271698
[TBL] [Abstract] [Full Text] [Related]
15. How I Diagnose Rosai-Dorfman Disease.
Ravindran A; Rech KL
Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
[TBL] [Abstract] [Full Text] [Related]
16. Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification.
Rizzo M; Caliò A; Brunelli M; Pezzicoli G; Ganini C; Martignoni G; Camillo P
Cancer Treat Rev; 2023 May; 116():102558. PubMed ID: 37060647
[TBL] [Abstract] [Full Text] [Related]
17. Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations.
Chen T; Peng Y; Lei T; Wu C; Wang H; Shi Y
Pathol Oncol Res; 2023; 29():1610852. PubMed ID: 36816543
[No Abstract] [Full Text] [Related]
18. What's new in the WHO 2022 classification of kidney tumours?
Alaghehbandan R; Siadat F; Trpkov K
Pathologica; 2022 Feb; 115(1):8-22. PubMed ID: 36645398
[TBL] [Abstract] [Full Text] [Related]
19. New insights in the new WHO classification of adult renal tumors.
Hes O; Michalová K; Pivovarčíková K
Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503
[TBL] [Abstract] [Full Text] [Related]
20. alk-rearranged renal cell carcinoma with TPM3::alk gene fusion and review of the literature.
Galea LA; Hildebrand MS; Witkowski T; Joy C; McEvoy CR; Hanegbi U; Aga A
Virchows Arch; 2023 Mar; 482(3):625-633. PubMed ID: 36370168
[TBL] [Abstract] [Full Text] [Related]
[Next]
